The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

Globe Investor

News Sources

Take control of your investments with the latest investing news and analysis

Press release from Business Wire

Illumina to Webcast Live Presentations at Upcoming Investment Conferences in June

Wednesday, May 30, 2012

Illumina to Webcast Live Presentations at Upcoming Investment Conferences in June06:30 EDT Wednesday, May 30, 2012 SAN DIEGO (Business Wire) -- Illumina, Inc. (NASDAQ:ILMN) today announced that it will webcast the company's presentations at two upcoming investment conferences. Illumina will webcast its presentation at the Goldman Sachs Global Healthcare Conference in Rancho Palos Verdes, California, on June 6, 2012. The live webcast is scheduled to begin at 12:20 p.m. ET and will feature an overview of the company by Jay Flatley, President and Chief Executive Officer, followed by a question and answer session. Illumina will also webcast its presentation at the William Blair & Company Growth Stock Conference in Chicago, Illinois on June 13, 2012. The live webcast is scheduled to begin at 9:40 a.m. ET and will feature an overview of the company by Christian Henry, Senior Vice President and General Manager, Genomic Solutions, followed by a question and answer session. These webcasts can be accessed in the Investor Relations section of Illumina's web site under the "Company" tab at www.illumina.com. About Illumina Illumina (www.illumina.com) is a leading developer, manufacturer, and marketer of life science tools and integrated systems for the analysis of genetic variation and function. We provide innovative sequencing and array-based solutions for genotyping, copy number variation analysis, methylation studies, gene expression profiling, and low-multiplex analysis of DNA, RNA and protein. We also provide tools and services that are fueling advances in consumer genomics and diagnostics. Our technology and products accelerate genetic analysis research and its application, paving the way for molecular medicine and ultimately transforming healthcare. Illumina, Inc.Investors:Kevin Williams, MDInvestor Relations858-332-4989kwilliams@illumina.comorMedia:Jennifer TemplePublic Relations858-429-8350PR@illumina.com